Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
종목 코드 CTKB
회사 이름Cytek Biosciences Inc
상장일Jul 23, 2021
CEOJiang (Wenbin)
직원 수648
유형Ordinary Share
회계 연도 종료Jul 23
주소47215 Lakeview Boulevard
도시FREMONT
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94538
전화18779229835
웹사이트https://cytekbio.com
종목 코드 CTKB
상장일Jul 23, 2021
CEOJiang (Wenbin)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음